Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kevin Koch

CEO, President at Edgewise Therapeutics, Inc. (EWTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $785K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell 8,78261,677 held (−12%) $43.64 $383K -14.8%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell 8,27653,401 held (−13%) $43.66 $361K -14.8%
Aug 14SEC EWTXEdgewise Therapeutics, Inc. Sell 91352,488 held (−2%) $44.33 $40K -16.1%